Related Experiment Video
Updated: Jun 13, 2026

Anogenital Distance and Perineal Measurements of the Pelvic Organ Prolapse (POP) Quantification System
Published on: September 20, 2018
Relationships between pelvic floor symptoms and function in irritable bowel syndrome
1Gastrointestinal Investigation Unit, Royal North Shore Hospital and University of Sydney, Sydney, NSW, Australia.
Pelvic floor dyssynergia (PFD) symptoms in non-diarrhea predominant IBS patients show links to anorectal function. However, symptoms alone do not predict PFD, indicating a need for further testing.
Area of Science:
- Gastroenterology
- Physiology
- Pelvic Floor Health
Background:
- Pelvic floor dyssynergia (PFD) is often overlooked in irritable bowel syndrome (IBS).
- The connection between PFD symptoms and anorectal physiology in IBS is not well understood.
- This study focuses on non-diarrhea predominant IBS (non-D IBS).
Purpose of the Study:
- To explore relationships between clinical features and anorectal function in non-D IBS patients.
- To identify if clinical or physiological features predict PFD in IBS patients.
- To investigate the association between PFD symptoms and disordered anorectal physiology.
Main Methods:
- Evaluated two groups of female non-D IBS patients.
- Group I (n=32) had PFD symptoms and underwent comprehensive symptom and anorectal function assessment.
- Group II (n=32) had symptom assessment only.
Main Results:
- Increased digitation frequency correlated with longer balloon expulsion time.
- Higher anal pain scores linked to low resting anal pressure and shorter maximum squeeze duration.
- Reduced perineal descent associated with anxiety and depression; shorter maximum squeeze linked to parity and hysterectomy.
Conclusions:
- Significant links exist between PFD symptoms and anorectal dysfunction in non-D IBS.
- Clinical symptoms alone are insufficient to diagnose PFD.
- Certain clinical features warrant comprehensive anorectal function testing for PFD diagnosis.
Related Concept Videos
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
